KLRK1 and exocrine pancreatic carcinoma: Khallouf et al. (48) reported that immunochemotherapy with 5-fluorouacil and IFN-α increased expression of major histocompatibility complex class-I and NKG2D ligands on murine pancreatic carcinoma (Panc02) cells, which could be useful for enhancing tumor immunogenicity.